Home / Cancer and immune system / Leuprorelin
ATC L02AE02 · Endocrine Therapy
Leuprorelin shortage
As of 31 Oct 2026, Leuprorelin has a reported shortage in 2 of the 5 countries we track (Italy, Austria), covering 6 products.
Countries2/5
Products6packs or presentations
Short since6 Feb 20269 months ago
Earliest return11 Jan 2027company estimate
No return date5products
Main reasonManufacturing problem
Timeline
ItalyAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | POLITRATE | SOPHOS BIOTECH S.R.L. | 6 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | LEPTOPROL | SANDOZ S.P.A. | 9 Jul 2026 | not given | Manufacturing problem Problemi produttivi |
| AT | Enantone Monats-Depot - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Enantone-Gyn Monats-Depot - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Trenantone - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Lutrate 3-Monats-Depot 22,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | Genericon Pharma Ges.m.b.H. | 13 Oct 2026 | 11 Jan 2027 | Manufacturing problem Verzögerung bei der Herstellung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.